Delivery Order SPE2DB22D3016-SPE2DB24FBFT4

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 4,560 units of 4 mg naloxone hydrochloride nasal spray. The $14,119.53 contract is an order under the company's existing $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to military healthcare...
The Defense Logistics Agency (DLA) awarded a $3,011.02 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,832,406 units of Naloxone HCL 4 mg nasal spray. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $1,359.46. The order is for the supply of 4 mg nasal spray naloxone hydrochloride, a medication used to treat opioid overdose. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and medical...
This federal contract award, valued at $1,039.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,830,894 units of Naloxone HCL 4 mg Nasal Spray 2S, a critical medication used to treat opioid overdoses. The contract is a Delivery Order with a Firm Fixed Price, with a completion date of May 5, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,061.84, is for the delivery of 4,567,475,840 units of Naloxone HCL 4 mg nasal spray, a critical medication used in the treatment of opioid overdoses. The contract is a firm-fixed-price delivery order with a period of performance through March 6, 2025. This award is part of a larger Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the provision of 4,561,027,452 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The award, valued at $2,931.70, has a firm fixed-price structure and an ultimate completion date of May 24, 2023. This contract is not set aside for any specific business type....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,486,292 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdose. The contract has a ceiling value of $20,243.49 and a completion date of March 7, 2025. This award is associated with a larger Indefinite Delivery Contract...
This is a $2,286.19 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,564,980,642 units of 4 mg naloxone hydrochloride nasal spray, a medication used to reverse opioid overdose. The contract has an ultimate completion date of June 25, 2024. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a firm fixed price of $1,342.48 and a period of performance through March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $1,211.88, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,450,464 units of Naloxone HCL 4 mg Nasal Spray, with an ultimate completion date of November 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBFT4
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,320.69 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,664,956 units of 4 mg naloxone hydrochloride nasal spray. This order is part of a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. This award is intended to supply critical naloxone medication, which is used to reverse opioid overdoses, to federal healthcare providers, including military treatment facilities and veterans' hospitals.

Generated 12/3/24, 9:44 AM